Leukemia is a kind of common malignant diseases of hematopoietic system. Patients had the disease, their blood and bone marrow in various tissues and organs where there are substantial morphological abnormalities of leukemia cells, such cells continue to hyperplasia, the patient can be a series of symptoms, because different types of leukocytes, clinical performance are also different. According to the degree of mature interleukin distinction can be divided into acute leukemia, chronic in two. Acute leukemia, patients are almost all of the leukemia cells are immature and childish to PMN as an example, mostly mice and tablets of leukemia, such as late promyelocyte cells. Here should indicate that the chronic leukemia not evolve from acute leukemia. Such as by white blood cells to distinguish between different types can be divided into type lymphocytes, granulocyte cell type, mononuclear cell, plasma cell type, megakaryocyte leukemia, and sometimes also by the mixture of two types of cells, such as tablets of one single cell of leukemia.
Leukemia is a malignant hematopoietic system. Characterized by bone marrow, lymph nodes, such as hematopoietic system in one or more components of blood cells of malignant happen, and infiltration of various tissues in vivo, resulting in inhibition of normal hematopoietic cells, resulting in a variety of symptoms. On leukemia often fever, bleeding, anemia, liver, spleen, lymph nodes characterized. Leukemia generally based on the natural course of disease and the extent of naive cells is divided into acute and chronic, by cell type is divided into granulocyte cells, lymphocytes, monocytes and other types of clinical manifestations have similarities and differences. May be traditional Chinese medicine and chemotherapy, the majority of up to ease, but also bone marrow transplant therapy, some may be long-term survival or even cure.
Leukemia Cancer is a common one, accounting for the incidence of tumor sixth place, about ten thousand people 3-4/10, one of acute than chronic, acute and above accounted for 70 percent, accounting for one of acute promyelocytic first, followed by ALL .